Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 5:12PM CST
Evotec AG (EVTCY) entered into a research collaboration agreement with C4X Discovery Holdings plc for the development of Orexin-1 selective inhibitors.
JNJ: 99.62 (+1.18), ENDP: 84.01 (+1.12), SNY: 49.42 (+0.82)